Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AIM:Pouch-vaginal fistula (PVF) is an uncommon but serious complication of ileo-anal pouch reconstruction. This study aimed to review the recent management of PVF, in particular the role of anti-TNF drugs. METHOD:All patients presenting for management of PVF to our surgical service between 2007 and 2016 were studied. Median duration of follow up from diagnosis of PVF was 6 years. Details of original pouch surgery, timing of presentation of PVF, management and final outcome were recorded. Primary outcome was gastrointestinal (GI) continuity (as defined by presence or absence of a stoma). RESULTS:A total of 23 patients were identified ( median age 45 years) of whom 9 had pelvic sepsis at the time of original pouch surgery. Management included local surgical repair, defunctioning ileostomy, pouch excision and anti-TNF therapy. Gastrointestinal continuity was achieved in 12 patients (52%). Healing of PVF was achieved in 12 patients (52%). Pelvic sepsis was significantly associated with the need for a long-term ileostomy (p=0.009). Biological therapy was used in 12 patients, of whom 7 maintained GI continuity. Patients with late presentation PVF (60 months or longer post-surgery) and those with clinical features of Crohn's disease appeared to benefit from anti-TNF treatment. CONCLUSION:PVF remains a challenging problem with overall healing rates and GI continuity rates of just over 50%. Anti-TNF therapy may have a role in patients with late presentation PVF and those with features suggestive of Crohn's disease.

Original publication

DOI

10.1111/codi.14904

Type

Journal article

Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Publication Date

11/11/2019

Addresses

Oxford Colorectal Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE.